Reassurance.ie - Covid Testing Revenue and Competitors
Estimated Revenue & Valuation
- Reassurance.ie - Covid Testing's estimated annual revenue is currently $201k per year.
- Reassurance.ie - Covid Testing's estimated revenue per employee is $201,000
Employee Data
- Reassurance.ie - Covid Testing has 1 Employees.
- Reassurance.ie - Covid Testing grew their employee count by 0% last year.
Reassurance.ie - Covid Testing's People
| Name | Title | Email/Phone |
|---|
Reassurance.ie - Covid Testing Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $110.8M | 551 | 19% | N/A | N/A |
#2 | $15.3M | 76 | -21% | N/A | N/A |
#3 | $17.3M | 86 | 16% | N/A | N/A |
#4 | $0.2M | 1 | 0% | N/A | N/A |
#5 | $73M | 363 | 46% | N/A | N/A |
#6 | $28.5M | 142 | 38% | N/A | N/A |
What Is Reassurance.ie - Covid Testing?
At Reassurance.ie our experienced Pharmacists and health care professionals provide both a high quality Covid-19 Antigen Test and Antibody Test. Our test offers you reassurance that you do not have Covid-19 antigens or antibodies present within 15 minutes
keywords:N/A
N/A
Total Funding
1
Number of Employees
$201k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Reassurance.ie - Covid Testing News
... reassurance for the general public; the study's authors concluded that most face masks tested were not a major source of PFAS exposure.
Whether through COVID-19 testing or vaccinations, customers and patients have ... reassurance knowing their experience is supported by the latest COVID-19...
Researchers tracked a cohort of BU students who'd tested positive for ... and that rapid antigen testing may provide reassurance of lack of...
Other Companies in Portlaoise
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $55.3M | 125 | 24% | N/A |
#2 | $40.5M | 145 | 29% | N/A |
#3 | $68.7M | 255 | 18% | N/A |
#4 | $100.4M | 281 | 22% | N/A |
#5 | $294.3M | 1001 | 18% | N/A |